21 October 2026 · 3 min read · By Clinical Trials
What Is a Clinical Study Report? An ICH E3 Guide for CROs and Sponsors
Learn what a clinical study report contains, how ICH E3 organises methods and results, and what CROs and sponsors should review before finalising a CSR.
A clinical study report, often abbreviated CSR, is a detailed account of a study’s design, conduct, analysis and results. It brings together the information needed to understand what was planned, what happened and what the findings mean. It is different from a short journal article, a recruitment listing or a participant’s medical record.
ICH E3 provides guidance on the structure and content of clinical study reports for clinical investigations of therapeutic, prophylactic or diagnostic agents in patients or healthy volunteers. Its use should be considered alongside the study type and applicable regulatory requirements; following a report structure does not itself prove that a study is high quality.
The core sections of a clinical study report
An E3-style report includes identifying information and a synopsis, followed by background, objectives and a description of the investigation. Methods explain participant selection, treatments, endpoints, study design and statistical approaches so the reader can understand how the research question was addressed.
The results sections describe participant disposition, the populations analysed, efficacy findings where relevant, and safety findings. Discussion and conclusions should reflect the evidence rather than repeat a desired commercial message. Tables, figures and appendices support the account with appropriate detail.
Explain what changed during the study
A useful CSR distinguishes the original plan from amendments and changes to the conduct or analysis. Relevant protocol deviations, withdrawals, missing observations and differences between planned and actual assessments need clear explanation. Their effect on interpretation should not be hidden in an appendix or overlooked.
For CROs, preparing this account requires coordination across clinical operations, data management, statistics, safety and medical writing. Consistent identifiers, version control and reconciled datasets make it easier to check that the narrative agrees with the supporting tables.
What sponsors should review before finalisation
Check that objectives and endpoints agree with the protocol and that analyses are explained against the statistical analysis plan. Participant totals should reconcile across disposition, analysis sets and safety summaries. Review whether adverse events, discontinuations and missing data are described consistently and whether conclusions acknowledge important limitations.
Resolve discrepancies with the responsible functions rather than editing the report simply to make results appear more favourable. Confirm applicable privacy, document-control and submission requirements before sharing participant-level material or finalising the report.
CSR, registry results and a lay summary are different
A registry results entry is structured public information; a lay summary explains findings for a non-specialist audience; a CSR is a more detailed technical account. They may describe the same study, but one should not be assumed to contain every detail of the others.
Use the current ICH E3 guideline and related questions-and-answers document as primary references, and confirm local requirements with qualified regulatory professionals. This article is an orientation, not a submission template or regulatory advice.